to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
In a venture funding climate seeking large returns, thousands of potentially successful entrepreneurial startups can't get the financing they need to make a difference in the economy and in the culture. The problem isn't a new one, but it is a damaging one.
Can "boom and bust" cycles exist in the venture funding market? You bet they can. And recent data from the chemical sector is a great example of how and why.
Medical foundations play a role in helping medicine advance through their philanthropy, but sometimes even the most well-intentioned of them can lose their way. Read more about how these foundations can stay focused on their goals.
Venture firms are approaching angel investor groups to co-invest at the growth stage of startups. Read more about the impact this could have on startup health IT companies.
The number of life sciences venture deals was down in the third quarter and first-time funding was down as well. Read more about the reasons behind the numbers.
As a partner at Kleiner Perkins Caufield & Byers, Dana Mead supports entrepreneurs and innovators seeking to make major impact through life science technologies and ventures. In this lecture, Mead talks about Venture Capital, offering great insights about Silicon Valley and life as a venture capitalist.
As year-end approaches and entrepreneurs regroup to figure out financing options for 2012, it's a good time to take a look at the two major sources of new business funding -- angel investing versus venture capital.
In Part Two of our look at early-stage entrepreneurial funding, we examine the pros and cons of the two primary startup funding mechanisms: venture capital and angel funding.
In the healthcare business landscape, there's plenty of healthcare investing happening. However, there are still medical problems that could benefit from more investment. Read more about them.
Nanotechnology firms will benefit from $3 million in grants from a Pennsylvania organization that wants to encourage innovation. Read more about this program for businesses and colleges.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
